Research Article
BibTex RIS Cite
Year 2021, Volume: 4 Issue: 5, 692 - 697, 05.09.2021
https://doi.org/10.32322/jhsm.952354

Abstract

Supporting Institution

Destekleyen bir kurum yoktur.

References

  • Taleghani N, Taghipour F. Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art. Biosens Bioelectron 2021; 174: 112830.
  • Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med 2021; 23: e3303.
  • Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020; 96: 753-8.
  • Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis - A review of current methods. Biosens Bioelectron 2021; 172: 112752.
  • Habas K, Nganwuchu C, Shahzad F, et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther 2020; 18: 1201-11.
  • Islam KU, Iqbal J. An Update on Molecular Diagnostics for COVID-19. Front Cell Infect Microbiol 2020; 10: 560616.
  • Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021; 20: 23-44.
  • Awadasseid A, Wu Y, Tanaka Y, Zhang W. Current advances in the development of SARS-CoV-2 vaccines. Int J Biol Sci 2021; 17: 8-19.
  • Sharma NK, Sarode SC, Sarode G, Patil S. Is a COVID-19 vaccine developed by nature already at work? Med Hypotheses 2020; 145: 110335.
  • Sreepadmanabh M, Sahu AK, Chande A. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci 2020; 45: 148.
  • Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci 2020; 27: 104.
  • Silveira MM, Moreira GMSG, Mendonça M. DNA vaccines against COVID-19: Perspectives and challenges. Life Sci 2021; 267: 118919.
  • Mehrotra DV, Janes HE, Fleming TR, et al. Clinical Endpoints for evaluating efficacy in COVID-19 vaccine trials. Ann Intern Med 2021; 174: 221-8.
  • Marian AJ. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries. Cardiovasc Pathol 2021; 50: 107278.
  • Liu X, Liu C, Liu G, Luo W, Xia N. COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics 2020; 10: 7821-35.
  • Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021; 170: 1-25.
  • Halstead SB, Katzelnick L. COVID-19 Vaccines: Should We Fear ADE? J Infect Dis 2020; 222: 1946-50.
  • Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360: 1981-8.
  • Kader Ç. Aşı Karşıtlığı: Aşı Kararsızlığı Ve Aşı Reddi. ESTÜDAM Halk Sağlığı Dergisi 2019; 4: 377-88.
  • Wakefield A, Murch S, Anthony A, et al. İleal-lenfoid-nodülerhiperplazi, spesifik olmayan kolit ve çocuklarda yaygın gelişimsel bozukluk. Lancet 1998; 351: 637–41.
  • Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum VaccinImmunother 2020; 16: 2586-93.
  • Argüt N, Yetim A, Gökçay G. Aşı kabulünü etkileyen faktörler. Çocuk Derg 2016; 16: 16-24.
  • Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers and their patients in Europe: A Qualitative Study. Vaccine 2016; 34: 5013-20.
  • Ergün E, Ergün Ş, Çelebi İ. Acil Sağlık Hizmetleri Personellerinin COVID-19 Hakkında Bilgi, Korunma Düzeyleri Ve Etkileyen Etmenler. JOPEHS 2020; 1: 16-27.
  • Arslanca T, Fidan C, Daggez M, Dursun P. Knowledge, preventive behaviors and risk perception of the COVID-19 pandemic: A cross-sectional study in Turkish health care workers. PLoS One 2021; 16: e0250017.
  • Gagneux-Brunon A, Detoc M, Bruel S, et al. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect 2021; 108: 168-73.
  • Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 2020; 35: 775-9.
  • Ünal S , Tanrıöver MD, Taş E, Güner İ, Çetin ÖY, Sayar İ. Aile Hekimlerine Eğitim Verilmesi Ve Aşılama Hedeflerinin Belirlenmesinin Pnömokok Aşılanma Oranları Üzerine Etkileri. FLORA 2015; 20: 10-15
  • Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021; 27: 225-8.
  • Biswas N, Mustapha T, Khubchandani J, Price JH. The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. J Community Health 2021; 20: 1–8.
  • Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf) 2020: fdaa230.
  • Kul G, Korkmaz N. Sağlık Çalışanlarının İnfluenza Aşılamasına Yaklaşımı. J Contemp Med 2020; 10: 421-4.
  • Sarı T, Temoçin F, Köse H. Sağlık çalışanlarının influenza aşısına yaklaşımları. Türkiye Klinik Derg 2017; 30: 59-63.

Exploring healthcare professionals’ views and approaches regarding COVID-19 vaccines

Year 2021, Volume: 4 Issue: 5, 692 - 697, 05.09.2021
https://doi.org/10.32322/jhsm.952354

Abstract

Aim: While going through tough times in the fight against the pandemic, the approach of healthcare professionals to vaccination can enlighten the way of society. In our study, we aimed to investigate healthcare professionals’ views and approaches regarding the COVID-19 vaccine.
Methods: We carried out the study with a total of 500 voluntary healthcare professionals between January 2021 and April 2021. We administered a survey consisting of 15 multiple choice questions to the participants and put their responses into statistical analyses.
Results: There were a total of 500 participants, among whom 168 were males (33.6%). The mean age of the participants was 39.68 (21-62). While the number of physicians was 48 (9.6%), there were 158 (31.6%) nurses and midwives and 294 (58.8%) other healthcare personnel. Most of the participants (84.4%) thought the COVID-19 was a fatal infection. Again, the majority of participants believed in the necessity of vaccines (87%) and, especially, the COVID-19 (73.2%). Besides, the rate of those who were vaccinated against COVID-19 was 82%. Interestingly, about half of the participants (54%) believed in the protective effect of the vaccine. The participants showed ineffectiveness (34%) and side effects (28%) as the frequent reasons for non-vaccination. Among those who were positive towards vaccination, 16.7% had not been vaccinated yet. A substantial rate of the participants (67.4%) recommended the COVID-19 vaccine to those around them, but 6.8% did not. Sixty-three per cent of the participants would trust the local vaccine more. Finally, 67% of the participants thought that the vaccine would play a significant role in ending the pandemic.
Conclusion: In our study, we discovered that the vast majority of healthcare professionals were vaccinated and adopted a positive approach to vaccination. In addition, relevant training programs may help increase the number of individuals adopting entirely positive attitudes towards the vaccine.

References

  • Taleghani N, Taghipour F. Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art. Biosens Bioelectron 2021; 174: 112830.
  • Mohamadian M, Chiti H, Shoghli A, Biglari S, Parsamanesh N, Esmaeilzadeh A. COVID-19: Virology, biology and novel laboratory diagnosis. J Gene Med 2021; 23: e3303.
  • Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020; 96: 753-8.
  • Yüce M, Filiztekin E, Özkaya KG. COVID-19 diagnosis - A review of current methods. Biosens Bioelectron 2021; 172: 112752.
  • Habas K, Nganwuchu C, Shahzad F, et al. Resolution of coronavirus disease 2019 (COVID-19). Expert Rev Anti Infect Ther 2020; 18: 1201-11.
  • Islam KU, Iqbal J. An Update on Molecular Diagnostics for COVID-19. Front Cell Infect Microbiol 2020; 10: 560616.
  • Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021; 20: 23-44.
  • Awadasseid A, Wu Y, Tanaka Y, Zhang W. Current advances in the development of SARS-CoV-2 vaccines. Int J Biol Sci 2021; 17: 8-19.
  • Sharma NK, Sarode SC, Sarode G, Patil S. Is a COVID-19 vaccine developed by nature already at work? Med Hypotheses 2020; 145: 110335.
  • Sreepadmanabh M, Sahu AK, Chande A. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development. J Biosci 2020; 45: 148.
  • Li YD, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci 2020; 27: 104.
  • Silveira MM, Moreira GMSG, Mendonça M. DNA vaccines against COVID-19: Perspectives and challenges. Life Sci 2021; 267: 118919.
  • Mehrotra DV, Janes HE, Fleming TR, et al. Clinical Endpoints for evaluating efficacy in COVID-19 vaccine trials. Ann Intern Med 2021; 174: 221-8.
  • Marian AJ. Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries. Cardiovasc Pathol 2021; 50: 107278.
  • Liu X, Liu C, Liu G, Luo W, Xia N. COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics 2020; 10: 7821-35.
  • Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021; 170: 1-25.
  • Halstead SB, Katzelnick L. COVID-19 Vaccines: Should We Fear ADE? J Infect Dis 2020; 222: 1946-50.
  • Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009; 360: 1981-8.
  • Kader Ç. Aşı Karşıtlığı: Aşı Kararsızlığı Ve Aşı Reddi. ESTÜDAM Halk Sağlığı Dergisi 2019; 4: 377-88.
  • Wakefield A, Murch S, Anthony A, et al. İleal-lenfoid-nodülerhiperplazi, spesifik olmayan kolit ve çocuklarda yaygın gelişimsel bozukluk. Lancet 1998; 351: 637–41.
  • Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum VaccinImmunother 2020; 16: 2586-93.
  • Argüt N, Yetim A, Gökçay G. Aşı kabulünü etkileyen faktörler. Çocuk Derg 2016; 16: 16-24.
  • Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers and their patients in Europe: A Qualitative Study. Vaccine 2016; 34: 5013-20.
  • Ergün E, Ergün Ş, Çelebi İ. Acil Sağlık Hizmetleri Personellerinin COVID-19 Hakkında Bilgi, Korunma Düzeyleri Ve Etkileyen Etmenler. JOPEHS 2020; 1: 16-27.
  • Arslanca T, Fidan C, Daggez M, Dursun P. Knowledge, preventive behaviors and risk perception of the COVID-19 pandemic: A cross-sectional study in Turkish health care workers. PLoS One 2021; 16: e0250017.
  • Gagneux-Brunon A, Detoc M, Bruel S, et al. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect 2021; 108: 168-73.
  • Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 2020; 35: 775-9.
  • Ünal S , Tanrıöver MD, Taş E, Güner İ, Çetin ÖY, Sayar İ. Aile Hekimlerine Eğitim Verilmesi Ve Aşılama Hedeflerinin Belirlenmesinin Pnömokok Aşılanma Oranları Üzerine Etkileri. FLORA 2015; 20: 10-15
  • Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021; 27: 225-8.
  • Biswas N, Mustapha T, Khubchandani J, Price JH. The nature and extent of COVID-19 vaccination hesitancy in healthcare workers. J Community Health 2021; 20: 1–8.
  • Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf) 2020: fdaa230.
  • Kul G, Korkmaz N. Sağlık Çalışanlarının İnfluenza Aşılamasına Yaklaşımı. J Contemp Med 2020; 10: 421-4.
  • Sarı T, Temoçin F, Köse H. Sağlık çalışanlarının influenza aşısına yaklaşımları. Türkiye Klinik Derg 2017; 30: 59-63.
There are 33 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Article
Authors

Reyhan Öztürk 0000-0002-0969-3961

Publication Date September 5, 2021
Published in Issue Year 2021 Volume: 4 Issue: 5

Cite

AMA Öztürk R. Exploring healthcare professionals’ views and approaches regarding COVID-19 vaccines. J Health Sci Med / JHSM. September 2021;4(5):692-697. doi:10.32322/jhsm.952354

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.